Novacea, Inc. and Transcept Pharmaceuticals, Inc. Announce Filing of Form S-4 Proxy/Registration Statement

SOUTH SAN FRANCISCO, CA and POINT RICHMOND, CA--(Marketwire - October 06, 2008) - Novacea, Inc. (NASDAQ: NOVC) and Transcept Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced today that on October 3, 2008, Novacea filed its Registration Statement on Form S-4 with the Securities and Exchange Commission (SEC) in connection with its proposed merger with Transcept. The definitive merger agreement was entered into on August 29, 2008.

Back to news